S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
Economists predict US inflation will keep cooling and the economy can avoid a recession
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
Economists predict US inflation will keep cooling and the economy can avoid a recession
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
Economists predict US inflation will keep cooling and the economy can avoid a recession
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
Economists predict US inflation will keep cooling and the economy can avoid a recession

2seventy bio Stock Price, News & Analysis (NASDAQ:TSVT)

$1.94
+0.11 (+6.01%)
(As of 12/1/2023 08:55 PM ET)
Compare
Today's Range
$1.68
$1.95
50-Day Range
$1.57
$4.49
52-Week Range
$1.54
$16.17
Volume
775,200 shs
Average Volume
1.17 million shs
Market Capitalization
$98.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.17

2seventy bio MarketRank™ Stock Analysis

Analyst Rating
Hold
2.14 Rating Score
Upside/​Downside
475.6% Upside
$11.17 Price Target
Short Interest
Bearish
26.17% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of 2seventy bio in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.99) to ($1.65) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

369th out of 957 stocks

Pharmaceutical Preparations Industry

158th out of 436 stocks


TSVT stock logo

About 2seventy bio Stock (NASDAQ:TSVT)

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

TSVT Stock Price History

TSVT Stock News Headlines

Biotech Stocks Facing FDA Decision In December 2023
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Wedbush Downgrades 2seventy bio (TSVT)
2seventy slides on latest roadblock for cancer drug
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
2seventy bio: Q3 Earnings Insights
2seventy bio earnings: here's what Wall Street expects
Preview: 2seventy bio's Earnings
2seventy bio to lay off 40% of workforce
Goldman Sachs Downgrades 2seventy bio (TSVT)
Guggenheim Downgrades 2seventy bio (TSVT)
The Latest Analyst Ratings for 2seventy bio
2seventy bio CEO to step down, plans job cuts
2seventy Bio Announces Restructuring, To Reduce 176 Roles
See More Headlines
Receive TSVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/03/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/21/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TSVT
Fax
N/A
Employees
425
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.17
High Stock Price Target
$26.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+475.6%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

Net Income
$-254,150,000.00
Net Margins
-126.06%
Pretax Margin
-126.06%

Debt

Sales & Book Value

Annual Sales
$91.50 million
Book Value
$6.05 per share

Miscellaneous

Free Float
49,309,000
Market Cap
$98.22 million
Optionable
Not Optionable
Beta
1.14
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report














TSVT Stock Analysis - Frequently Asked Questions

Should I buy or sell 2seventy bio stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 2seventy bio in the last year. There are currently 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" TSVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TSVT, but not buy additional shares or sell existing shares.
View TSVT analyst ratings
or view top-rated stocks.

What is 2seventy bio's stock price target for 2024?

7 analysts have issued 12 month price objectives for 2seventy bio's shares. Their TSVT share price targets range from $4.00 to $26.00. On average, they anticipate the company's share price to reach $11.17 in the next year. This suggests a possible upside of 475.6% from the stock's current price.
View analysts price targets for TSVT
or view top-rated stocks among Wall Street analysts.

How have TSVT shares performed in 2023?

2seventy bio's stock was trading at $9.37 at the beginning of the year. Since then, TSVT stock has decreased by 79.3% and is now trading at $1.94.
View the best growth stocks for 2023 here
.

When is 2seventy bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024.
View our TSVT earnings forecast
.

What ETFs hold 2seventy bio's stock?
Who are 2seventy bio's major shareholders?

2seventy bio's stock is owned by many different retail and institutional investors. Top institutional shareholders include Kynam Capital Management LP (11.80%), Newtyn Management LLC (6.10%), Wellington Management Group LLP (5.91%), CHI Advisors LLC (1.99%), Jacobs Levy Equity Management Inc. (1.54%) and Charles Schwab Investment Management Inc. (1.08%). Insiders that own company stock include Kynam Capital Management, Lp, Nick Leschly, Nicola Heffron, Philip D Gregory and William D Baird III.
View institutional ownership trends
.

How do I buy shares of 2seventy bio?

Shares of TSVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:TSVT) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -